Can a skin cream make immunotherapy more effective?
Disease control
Recruiting now
This early-stage trial tests whether a topical cream called diphencyprone (DPCP) can help standard immunotherapy work better in people with advanced cancer that has spread to the skin. About 100 participants will apply DPCP twice a week for 12 weeks alongside their usual PD-1 or …
Phase: PHASE1 • Sponsor: Nicholas Gulati • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC